Takeda Pharmaceutical Company Limited
TAK · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $385,113 | $457,800 | $533,530 | $849,695 |
| Short-Term Investments | $20,476 | $15,089 | $20,174 | $25,305 |
| Receivables | $725,254 | $697,610 | $681,694 | $724,378 |
| Inventory | $1,217,349 | $1,209,869 | $986,457 | $853,167 |
| Other Curr. Assets | $173,000 | $178,212 | $176,101 | $141,097 |
| Total Curr. Assets | $2,521,192 | $2,558,580 | $2,397,956 | $2,593,642 |
| Property Plant & Equip (Net) | $1,968,209 | $1,989,777 | $1,691,229 | $1,582,800 |
| Goodwill | $5,324,430 | $5,410,067 | $4,790,723 | $4,407,749 |
| Intangibles | $3,631,560 | $4,274,682 | $4,269,657 | $3,818,544 |
| Long-Term Investments | $361,926 | $430,608 | $378,857 | $330,133 |
| Tax Assets | $370,745 | $393,865 | $366,003 | $362,539 |
| Other NC Assets | $70,282 | $51,214 | $63,325 | $82,611 |
| Total NC Assets | $11,727,152 | $12,550,214 | $11,559,794 | $10,584,377 |
| Other Assets | $0 | -$2 | $0 | -$1 |
| Total Assets | $14,248,344 | $15,108,792 | $13,957,750 | $13,178,018 |
| Liabilities | – | – | – | – |
| Payables | $308,450 | $319,955 | $307,453 | $295,934 |
| Short-Term Debt | $548,939 | $367,251 | $339,600 | $203,993 |
| Tax Payable | $0 | $109,906 | $232,377 | $200,918 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,649,132 | $1,515,991 | $1,602,510 | $1,444,885 |
| Total Curr. Liab. | $2,506,521 | $2,313,103 | $2,481,940 | $2,145,730 |
| LT Debt | $3,966,326 | $4,476,501 | $4,042,741 | $4,141,418 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $35,153 | $113,777 | $270,620 | $451,511 |
| Other NC Liab. | $804,365 | $931,406 | $807,778 | $755,836 |
| Total NC Liab. | $4,805,844 | $5,521,684 | $5,121,139 | $5,348,765 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7,312,365 | $7,834,787 | $7,603,079 | $7,494,495 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,694,685 | $1,676,596 | $1,676,345 | $1,676,263 |
| Retained Earnings | $1,187,586 | $1,391,203 | $1,541,146 | $1,479,716 |
| AOCI | $2,351,915 | $2,509,310 | $1,508,119 | $934,173 |
| Other Equity | $1,700,898 | $1,696,155 | $1,628,512 | $1,592,867 |
| Total Equity | $6,935,084 | $7,273,264 | $6,354,122 | $5,683,019 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $895 | $741 | $549 | $504 |
| Total Liab. & Tot. Equity | $14,248,344 | $15,108,792 | $13,957,750 | $13,178,018 |
| Net Debt | $4,130,152 | $4,385,952 | $3,848,811 | $3,495,716 |